4.7 Article

Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children

Kendra K. Radtke et al.

Summary: Limited data on the pharmacokinetics and safety of moxifloxacin in children, especially in those with rifampin-resistant tuberculosis, were evaluated in this study. The results suggest that higher doses of moxifloxacin are needed to achieve adult exposures in young children, and further safety assessment is required, particularly when coadministered with other QT-prolonging agents.

CLINICAL INFECTIOUS DISEASES (2022)

Article Biochemistry & Molecular Biology

CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis

Antoine Merien et al.

Summary: This study used human pluripotent stem cells to investigate the role of MBNL proteins in human myogenesis, showing that they are crucial for late myogenic maturation and that loss of MBNL1 and MBNL2 can recapitulate features of DM1. Transcriptomic analyses revealed misregulated processes in DM1, providing insights for potential therapeutic strategies targeting MBNL protein dysfunction.

HUMAN MOLECULAR GENETICS (2022)

Article Clinical Neurology

Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway

Domenico D'Amico et al.

Summary: This study reveals that the IRE1 alpha/XBP1 branch of the unfolded protein response is disrupted in spinal muscular atrophy (SMA), with a depletion of XBP1s contributing to SMA pathogenesis. Rebalancing XBP1s expression can induce SMN expression and protect spinal motor neurons in severe SMA-like mice.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Review Economics

Costs of Illness of Spinal Muscular Atrophy: A Systematic Review

Erik Landfeldt et al.

Summary: This study conducted a systematic literature review on estimates of costs of illness of spinal muscular atrophy (SMA) from multiple countries, revealing significant variations in costs across different countries and disease types, with most studies exhibiting bias risks.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2021)

Review Pharmacology & Pharmacy

Therapeutic interventions for spinal muscular atrophy: preclinical and early clinical development opportunities

Laurent Servais et al.

Summary: The current drug treatments for SMA cannot cure the disease, and there remains a significant unmet need for patients treated after symptom onset. Clinical development of new drugs for SMA is challenging due to the heterogeneity of the patient population, variability in response to initial therapy, age at treatment onset, and the requirement to demonstrate added value beyond approved therapeutics.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Review Cell Biology

Neuromuscular Development and Disease: Learning From in vitro and in vivo Models

Zachary Fralish et al.

Summary: The neuromuscular junction (NMJ) is a crucial interface between motor neurons and skeletal muscle fibers that is essential for motor function. This review discusses the development of in vitro models of human NMJs derived from induced pluripotent stem cells (hiPSCs) and compares the efficacy of modeling neuromuscular diseases (NMDs) in animals and cell culture systems. Further research is needed to develop effective personalized NMD platforms using hiPSC-derived NMJ models.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Genetics & Heredity

Twenty-Five Years of Spinal Muscular Atrophy Research: From Phenotype to Genotype to Therapy, and What Comes Next

Brunhilde Wirth et al.

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020 (2020)

Article Biochemistry & Molecular Biology

Drosophila SMN2 minigene reporter model identifies moxifloxacin as a candidate therapy for SMA

Piotr Konieczny et al.

FASEB JOURNAL (2020)

Article Medicine, Research & Experimental

Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models

Jeong-Ki Kim et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Clinical Neurology

Spinal muscular atrophy - insights and challenges in the treatment era

Eugenio Mercuri et al.

NATURE REVIEWS NEUROLOGY (2020)

Review Pharmacology & Pharmacy

Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment

Giovanna Menduti et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

Crashing the computer: apoptosis vs. necroptosis in neuroinflammation

Bradlee L. Heckmann et al.

CELL DEATH AND DIFFERENTIATION (2019)

Article Clinical Neurology

Teaching an old drug new tricks: repositioning strategies for spinal muscular atrophy

Joseph M. Hoolachan et al.

FUTURE NEUROLOGY (2019)

Article Neurosciences

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy

Marina Boido et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Article Biochemical Research Methods

MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery

Joanne Young et al.

SLAS DISCOVERY (2018)

Review Biotechnology & Applied Microbiology

Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial

Celine Vandamme et al.

HUMAN GENE THERAPY (2017)

Letter Clinical Neurology

Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4

Renske I. Wadman et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)

Article Neurosciences

Defects in Motoneuron-Astrocyte Interactions in Spinal Muscular Atrophy

Chunyi Zhou et al.

JOURNAL OF NEUROSCIENCE (2016)

Review Anatomy & Morphology

Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy

Marina Boido et al.

FRONTIERS IN NEUROANATOMY (2016)

Article Biochemistry & Molecular Biology

Astrocytes influence the severity of spinal muscular atrophy

Hansjoerg Rindt et al.

HUMAN MOLECULAR GENETICS (2015)

Article Multidisciplinary Sciences

Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model

Valeria Valsecchi et al.

PLOS ONE (2015)

Review Anatomy & Morphology

Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Monir Shababi et al.

JOURNAL OF ANATOMY (2014)

Article Clinical Neurology

Abnormalities in Early Markers of Muscle Involvement Support a Delay in Myogenesis in Spinal Muscular Atrophy

Rebeca Martinez-Hernandez et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)

Article Biochemical Research Methods

Prediction of death in the SMNΔ7 mouse model of spinal muscular atrophy: Insight into disease stage and progression

Bassem F. El-Khodor et al.

JOURNAL OF NEUROSCIENCE METHODS (2012)

Article Cell Biology

Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction

Marc F. Bolliger et al.

JOURNAL OF CELL SCIENCE (2010)

Article Biochemistry & Molecular Biology

Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy

Shingo Kariya et al.

HUMAN MOLECULAR GENETICS (2008)

Article Neurosciences

Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy

Li-Kai Tsai et al.

NEUROBIOLOGY OF DISEASE (2008)

Article Biochemical Research Methods

Method for isolation of PCR-ready genomic DNA from zebrafish tissues

Nathan D. Meeker et al.

BIOTECHNIQUES (2007)

Article Biotechnology & Applied Microbiology

Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice

Ming S. Tsai et al.

MOLECULAR THERAPY (2006)

Article Biochemistry & Molecular Biology

Systemic inflammation induces apoptosis with variable vulnerability of different brain regions

A Semmler et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2005)